The Erythromycin Stearate Tablets, cataloged under National Stock Number 6505-01-218-3860, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Medical Technologies System Inc Vangard Labs Div. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 6 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-218-3860 |
| Primary Part Number | NDC00615-0124-01 |
| Item Name | Erythromycin Stearate Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Medical Technologies System Inc Vangard Labs Div |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Therapeutic Equivalent | VANGARD LABS. |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 250.000 MILLIGRAMS ERYTHROMYCIN EQUIVALENT |
| Primary Container Content Quantity | 250.000 TABLETS |
| Administration | ORAL |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00615-0124-01 PRIMARY | Medical Technologies System Inc Vangard Labs Div (USA) |
| 1120-00 PRIMARY | Medical Technologies System Inc Vangard Labs Div (USA) |
NSN 6505-01-218-3860 is a Erythromycin Stearate Tablets, manufactured by Medical Technologies System Inc Vangard Labs Div, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-218-3860 has 2 cross-referenced part numbers: NDC00615-0124-01 (Medical Technologies System Inc Vangard Labs Div), 1120-00 (Medical Technologies System Inc Vangard Labs Div).
There are 6 known substitutes for 6505-01-218-3860: 5930-00-424-8997, 5310-00-627-6128, 5895-00-702-4045 and 3 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00615-0124-01: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Therapeutic Equivalent: VANGARD LABS.; Primary Container Type: BOTTLE; Special Features: COATING FEATURE:NONENERTIC FILM. 7 total characteristics are documented in the Federal Logistics Information System.